Security key
004225108
ACADIA PHARMACEUTICALS INC - COMMON STOCK (ACAD)
CUSIP: 004225108
Q1 2025 13F Holders as of 31 Mar 2025
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 171,490,817
- Total 13F value
- $2,848,881,391
- Share change
- +8,832,496
- Put/Call ratio
- 17%
- SEC-reported price per share
- $16.61
- Number of holders
- 315
- Value change
- +$139,123,298
- Number of buys
- 159
- Number of sells
- 136
- Shares outstanding
- 171,249,283
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2025
Institutions
315
Top holders
10
ACAD full security history
Ownership snapshot
Full 13F holder table
ACADIA PHARMACEUTICALS INC SEC filings
ACADIA PHARMACEUTICALS INC company facts
Broader feeds
Ownership snapshot
Top reported holders of ACAD - ACADIA PHARMACEUTICALS INC - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BlackRock, Inc.
Disclosed value leader
BAKER BROS. ADVISORS LP
Comparable rows
15/15
Latest evidence
31 Jan 2025
13D/G
13F
Lead comparable stake: 12%
13D/G row: BlackRock, Inc.
Showing 1-6 of 15 holder rows.
Quick read
BlackRock, Inc. leads the comparable SEC ownership view at 12%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BlackRock, Inc.'s linked filing trail.
Comparable ownership
Top 5
BlackRock, Inc.
12%
BAKER BROS. ADVISORS LP
25%
VANGUARD GROUP INC
8.1%
RTW INVESTMENTS, LP
5.1%
MORGAN STANLEY
4.3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BlackRock, Inc. |
13D/G
13F
Company
|
12%
|
$292,813,929
19,878,746 shares
|
$0 | 31 Jan 2025 |
| BAKER BROS. ADVISORS LP |
13F
Company
|
25%
|
$786,809,759
42,877,916 shares
|
— | 31 Dec 2024 |
| VANGUARD GROUP INC |
13F
Company
|
8.1%
|
$255,939,195
13,947,640 shares
|
— | 31 Dec 2024 |
| RTW INVESTMENTS, LP |
13F
Company
|
5.1%
|
$159,745,943
8,705,501 shares
|
— | 31 Dec 2024 |
| MORGAN STANLEY |
13F
Company
|
4.3%
|
$133,900,859
7,297,049 shares
|
— | 31 Dec 2024 |
| STATE STREET CORP |
13F
Company
|
2.6%
|
$82,967,415
4,521,385 shares
|
— | 31 Dec 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
315
Shares
171,490,817
Rows available
315
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2025 vs Q1 2025 Across Filers
Q1 2025 holders
315
Q1 2025 holders
315
Holder diff
0
| Investor | Q1 2025 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q1 2025 value | Value change | Value Chg % |
|---|